Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.1.1.37 extracted from

  • Becker, A.; Kohfeld, S.; Lader, A.; Preu, L.; Pies, T.; Wieking, K.; Ferandin, Y.; Knockaert, M.; Meijer, L.; Kunick, C.
    Development of 5-benzylpaullones and paullone-9-carboxylic acid alkyl esters as selective inhibitors of mitochondrial malate dehydrogenase (mMDH) (2010), Eur. J. Med. Chem., 45, 335-342.
    View publication on PubMed

Application

Application Comment Organism
drug development mitochondrial malate dehydrogenase is a biological target for antiproliferative activity Sus scrofa

Inhibitors

Inhibitors Comment Organism Structure
11-chloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 65.3% inhibition at 0.010 mM Sus scrofa
2,3-dimethoxy-6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carbonitrile 89.2% inhibition at 0.010 mM Sus scrofa
2,3-dimethoxy-9-(trifluoromethyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 97.7% inhibition at 0.010 mM Sus scrofa
3-methoxy-9-trifluormethyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 83.9% inhibition at 0.010 mM Sus scrofa
4-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 87.6% inhibition at 0.010 mM Sus scrofa
5-(3,4-dichlorobenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
5-(4-methylbenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
5-benzyl-9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 8.6% inhibition at 0.010 mM Sus scrofa
5-benzyl-9-chloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
5-benzyl-9-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
5-benzyl-9-methyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
5-benzyl-9-tert-butyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
5-benzyl-9-trifluoromethyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carbonitrile 91.3% inhibition at 0.010 mM Sus scrofa
6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylic acid 98.7% inhibition at 0.010 mM Sus scrofa
7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 78.7% inhibition at 0.010 mM Sus scrofa
8,10-dichloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 28.7% inhibition at 0.010 mM Sus scrofa
9-(methylsulfinyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 96.2% inhibition at 0.010 mM Sus scrofa
9-(methylthio)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 76.6% inhibition at 0.010 mM Sus scrofa
9-(trifluoromethyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 88.3% inhibition at 0.010 mM Sus scrofa
9-bromo-12-(prop-2-en-1-yl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 74.1% inhibition at 0.010 mM Sus scrofa
9-bromo-12-methyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 98.0% inhibition at 0.010 mM Sus scrofa
9-bromo-2,3-dimethoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 56.3% inhibition at 0.010 mM Sus scrofa
9-bromo-2-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 58.7% inhibition at 0.010 mM Sus scrofa
9-bromo-3-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 15.0% inhibition at 0.010 mM Sus scrofa
9-bromo-4-hydroxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 25.9% inhibition at 0.010 mM Sus scrofa
9-bromo-4-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 82.0% inhibition at 0.010 mM Sus scrofa
9-bromo-5-(3,4-dichlorobenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
9-bromo-5-(4-methoxybenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
9-bromo-5-(4-methylbenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
9-bromo-5-methyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 81.9% inhibition at 0.010 mM Sus scrofa
9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 74.5% inhibition at 0.010 mM Sus scrofa
9-chloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 73.4% inhibition at 0.010 mM Sus scrofa
9-fluoro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 46.2% inhibition at 0.010 mM Sus scrofa
9-methyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 87.8% inhibition at 0.010 mM Sus scrofa
9-nitro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one 54.2% inhibition at 0.010 mM Sus scrofa
9-tert-butyl-5-(3,4-dichlorobenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
Sus scrofa
butyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
Sus scrofa
ethyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
Sus scrofa
hexyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
Sus scrofa
methyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate 60.9% inhibition at 0.010 mM Sus scrofa
additional information development of 5-benzylpaullones and paullone-9-carboxylic acid alkyl esters as selective inhibitors of mMDH, overview Sus scrofa
octyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
Sus scrofa
pentyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
Sus scrofa
propyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
Sus scrofa

Localization

Localization Comment Organism GeneOntology No. Textmining
mitochondrion isozyme mMDH Sus scrofa 5739
-

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
(S)-malate + NAD+ Sus scrofa
-
oxaloacetate + NADH + H+
-
r

Organism

Organism UniProt Comment Textmining
Sus scrofa
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
commercial preparation
-
Sus scrofa
-
heart
-
Sus scrofa
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
(S)-malate + NAD+
-
Sus scrofa oxaloacetate + NADH + H+
-
r

Synonyms

Synonyms Comment Organism
mitochondrial malate dehydrogenase
-
Sus scrofa
mMDH
-
Sus scrofa

Temperature Optimum [°C]

Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
25
-
assay at Sus scrofa

pH Optimum

pH Optimum Minimum pH Optimum Maximum Comment Organism
8.5
-
assay at Sus scrofa

Cofactor

Cofactor Comment Organism Structure
NAD+
-
Sus scrofa
NADH
-
Sus scrofa

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.00077
-
pH 8.5, 25°C Sus scrofa 9-tert-butyl-5-(3,4-dichlorobenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0011
-
pH 8.5, 25°C Sus scrofa 9-bromo-5-(3,4-dichlorobenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0016
-
pH 8.5, 25°C Sus scrofa 5-benzyl-9-tert-butyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0016
-
pH 8.5, 25°C Sus scrofa 9-bromo-5-(4-methylbenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0018
-
pH 8.5, 25°C Sus scrofa 9-bromo-5-(4-methoxybenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0024
-
pH 8.5, 25°C Sus scrofa 5-benzyl-9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0027
-
pH 8.5, 25°C Sus scrofa 5-benzyl-9-chloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0027
-
pH 8.5, 25°C Sus scrofa octyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
0.0042
-
pH 8.5, 25°C Sus scrofa 5-benzyl-9-trifluoromethyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0043
-
pH 8.5, 25°C Sus scrofa hexyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
0.0044
-
pH 8.5, 25°C Sus scrofa pentyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
0.0062
-
pH 8.5, 25°C Sus scrofa 5-benzyl-9-methyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0062
-
pH 8.5, 25°C Sus scrofa propyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
0.0079
-
pH 8.5, 25°C Sus scrofa 5-(3,4-dichlorobenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0099
-
pH 8.5, 25°C Sus scrofa butyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
0.0105
-
pH 8.5, 25°C Sus scrofa 5-(4-methylbenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0119
-
pH 8.5, 25°C Sus scrofa 5-benzyl-9-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
0.0135
-
pH 8.5, 25°C Sus scrofa methyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
0.02
-
pH 8.5, 25°C Sus scrofa ethyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate

General Information

General Information Comment Organism
additional information mMDH inhibition is of minor relevance for the growth inhibition caused by paullones Sus scrofa